July 20, 2023
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index



The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)

Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.


What the six ranks mean

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:

Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

Special Analysis: TOP 10 Dividend Investment Strategy

Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of July 20, 2023.

TOP 10 Dividend Investment Strategy Value Strategy DIVIDEND Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Pfizer (XXL, US)  Pharmaceuticals
1. Pfizer (XXL, US)   Pharmaceuticals 100 98 75 58
2. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 98 94 70 49
3. Phibro Animal (L, US)  Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals 98 100 95 83
4. Johnson & Johnson (XXL, US)  Pharmaceuticals
4. Johnson & Johnson (XXL, US)   Pharmaceuticals 96 63 49 31
5. Merck & Co. (XXL, US)  Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 94 55 65 60
6. Eli Lilly (XXL, US)  Pharmaceuticals
6. Eli Lilly (XXL, US)   Pharmaceuticals 85 23 35 74
7. Zoetis (XL, US)  Pharmaceuticals
7. Zoetis (XL, US)   Pharmaceuticals 85 23 16 49

☀ This company has a special achievement which is documented on its stock research page.

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy

TOP 10 Obermatt 360° Investment Strategy 360° Strategy 360° VIEW Value Strategy VALUE Combined Strategy COMBINED Sentiment Strategy SENTIMENT
1. Assertio Therapeutics (S, US)   Pharmaceuticals
1. Assertio Therapeutics (S, US)   Pharmaceuticals 93 73 96 67
2. Amphastar (M, US)   Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals 89 4 79 86
3. Heska (S, US)   Health Care Equipment
3. Heska (S, US)   Health Care Equipment 88 40 55 46
4. Phibro Animal (L, US)   Pharmaceuticals
4. Phibro Animal (L, US)   Pharmaceuticals 83 100 95 18
5. Prestige (L, US)   Pharmaceuticals
5. Prestige (L, US)   Pharmaceuticals 76 49 44 96
6. Eli Lilly (XXL, US)   Pharmaceuticals
6. Eli Lilly (XXL, US)   Pharmaceuticals 74 23 35 90
7. Pacira BioSciences (M, US)   Pharmaceuticals
7. Pacira BioSciences (M, US)   Pharmaceuticals 70 45 44 78
8. Merck & Co. (XXL, US)   Pharmaceuticals
8. Merck & Co. (XXL, US)   Pharmaceuticals 60 55 65 60
9. Pfizer (XXL, US)   Pharmaceuticals
9. Pfizer (XXL, US)   Pharmaceuticals 58 98 75 40
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 49 94 70 42

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy

TOP 10 Sentiment Investment Strategy Sentiment Strategy SENTIMENT Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Zoetis (XL, US)   Pharmaceuticals
1. Zoetis (XL, US)   Pharmaceuticals 96 23 16 49
2. Prestige (L, US)   Pharmaceuticals
2. Prestige (L, US)   Pharmaceuticals 96 49 44 76
3. Eli Lilly (XXL, US)   Pharmaceuticals
3. Eli Lilly (XXL, US)   Pharmaceuticals 90 23 35 74
4. Amphastar (M, US)   Pharmaceuticals
4. Amphastar (M, US)   Pharmaceuticals 86 4 79 89
5. Pacira BioSciences (M, US)   Pharmaceuticals
5. Pacira BioSciences (M, US)   Pharmaceuticals 78 45 44 70
6. Assertio Therapeutics (S, US)   Pharmaceuticals
6. Assertio Therapeutics (S, US)   Pharmaceuticals 67 73 96 93
7. Merck & Co. (XXL, US)   Pharmaceuticals
7. Merck & Co. (XXL, US)   Pharmaceuticals 60 55 65 60
8. Supernus Pharma (M, US)   Pharmaceuticals
8. Supernus Pharma (M, US)   Pharmaceuticals 54 16 14 18
9. Heska (S, US)   Health Care Equipment
9. Heska (S, US)   Health Care Equipment 46 40 55 88
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
10. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 42 94 70 49

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value Investment Strategy Value Strategy VALUE Growth Strategy GROWTH Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Phibro Animal (L, US)   Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals 100 35 95 83
2. Pfizer (XXL, US)   Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals 98 11 75 58
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 94 41 70 49
4. Nektar (XS, US)   Pharmaceuticals
4. Nektar (XS, US)   Pharmaceuticals 78 5 69 28
5. Assertio Therapeutics (S, US)   Pharmaceuticals
5. Assertio Therapeutics (S, US)   Pharmaceuticals 73 67 96 93
6. Johnson & Johnson (XXL, US)   Pharmaceuticals
6. Johnson & Johnson (XXL, US)   Pharmaceuticals 63 25 49 31
7. Merck & Co. (XXL, US)   Pharmaceuticals
7. Merck & Co. (XXL, US)   Pharmaceuticals 55 63 65 60
8. Prestige (L, US)   Pharmaceuticals
8. Prestige (L, US)   Pharmaceuticals 49 57 44 76
9. Pacira BioSciences (M, US)   Pharmaceuticals
9. Pacira BioSciences (M, US)   Pharmaceuticals 45 47 44 70
10. Heska (S, US)   Health Care Equipment
10. Heska (S, US)   Health Care Equipment 40 31 55 88

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth Investment Strategy Growth Strategy GROWTH Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Eli Lilly (XXL, US)   Pharmaceuticals
1. Eli Lilly (XXL, US)   Pharmaceuticals 91 23 35 74
2. Amphastar (M, US)   Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals 91 4 79 89
3. Assertio Therapeutics (S, US)   Pharmaceuticals
3. Assertio Therapeutics (S, US)   Pharmaceuticals 67 73 96 93
4. Merck & Co. (XXL, US)   Pharmaceuticals
4. Merck & Co. (XXL, US)   Pharmaceuticals 63 55 65 60
5. Prestige (L, US)   Pharmaceuticals
5. Prestige (L, US)   Pharmaceuticals 57 49 44 76
6. Zoetis (XL, US)   Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals 55 23 16 49
7. Pacira BioSciences (M, US)   Pharmaceuticals
7. Pacira BioSciences (M, US)   Pharmaceuticals 47 45 44 70
8. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
8. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 41 94 70 49
9. Phibro Animal (L, US)   Pharmaceuticals
9. Phibro Animal (L, US)   Pharmaceuticals 35 100 95 83
10. Heska (S, US)   Health Care Equipment
10. Heska (S, US)   Health Care Equipment 31 40 55 88

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety Investment Strategy Safety Strategy SAFETY Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Nektar (XS, US)  Pharmaceuticals
1. Nektar (XS, US)   Pharmaceuticals 91 78 69 28
2. Amphastar (M, US)  Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals 91 4 79 89
3. Assertio Therapeutics (S, US)  Pharmaceuticals
3. Assertio Therapeutics (S, US)   Pharmaceuticals 87 73 96 93
4. Phibro Animal (L, US)  Pharmaceuticals
4. Phibro Animal (L, US)   Pharmaceuticals 82 100 95 83
5. Heska (S, US)  Health Care Equipment
5. Heska (S, US)   Health Care Equipment 79 40 55 88
6. Pfizer (XXL, US)  Pharmaceuticals
6. Pfizer (XXL, US)   Pharmaceuticals 76 98 75 58
7. Supernus Pharma (M, US)  Pharmaceuticals
7. Supernus Pharma (M, US)   Pharmaceuticals 73 16 14 18
8. Johnson & Johnson (XXL, US)  Pharmaceuticals
8. Johnson & Johnson (XXL, US)   Pharmaceuticals 64 63 49 31
9. Pacira BioSciences (M, US)  Pharmaceuticals
9. Pacira BioSciences (M, US)   Pharmaceuticals 58 45 44 70
10. Merck & Co. (XXL, US)  Pharmaceuticals
10. Merck & Co. (XXL, US)   Pharmaceuticals 49 55 65 60

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined Investment Strategy Combined Strategy COMBINED Value Strategy VALUE Growth Strategy GROWTH 360° Strategy 360° VIEW
1. Assertio Therapeutics (S, US)  Pharmaceuticals
1. Assertio Therapeutics (S, US)   Pharmaceuticals 96 73 67 93
2. Phibro Animal (L, US)  Pharmaceuticals
2. Phibro Animal (L, US)   Pharmaceuticals 95 100 35 83
3. Amphastar (M, US)  Pharmaceuticals
3. Amphastar (M, US)   Pharmaceuticals 79 4 91 89
4. Pfizer (XXL, US)  Pharmaceuticals
4. Pfizer (XXL, US)   Pharmaceuticals 75 98 11 58
5. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
5. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 70 94 41 49
6. Nektar (XS, US)  Pharmaceuticals
6. Nektar (XS, US)   Pharmaceuticals 69 78 5 28
7. Merck & Co. (XXL, US)  Pharmaceuticals
7. Merck & Co. (XXL, US)   Pharmaceuticals 65 55 63 60
8. Heska (S, US)  Health Care Equipment
8. Heska (S, US)   Health Care Equipment 55 40 31 88
9. Johnson & Johnson (XXL, US)  Pharmaceuticals
9. Johnson & Johnson (XXL, US)   Pharmaceuticals 49 63 25 31
10. Prestige (L, US)  Pharmaceuticals
10. Prestige (L, US)   Pharmaceuticals 44 49 57 76

July 20, 2023. Top 10s are published weekly following the . ( or for more stocks)


☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from July 20, 2023.

Today's Top 10
More Top Stocks
Your Watchlist

Top 10 Stock History D.J. US Pharmaceutical



Obermatt Portfolio Performance
We’re so convinced about our research, that we buy our stock tips.
See the performance of the Obermatt portfolio.